Highlights By reviewing 120 Target Product Profiles (TPPs), this study identified key aspects of TPP development processes, stakeholder involvement, common themes, major limitations, and priorities for follow-up research. Health technologies were classified into five categories, and the pr

Tuberculosis is caused by bacterium called Mycobacterium tuberculosis. It is a significant problem in Thailand as seen that in 2021 Thailand is in the World Health Organization’s list of 30 high-burden countries for tuberculosis. One of the problems about tuberculosis is inaccurate diagnosis due to insufficient sensitivity and specificity of prim

66183067HM017L0medical innovation,Early HTA,Health Technology

68136067MU028L0medical innovation,health technology assessment,health economic evaluation,target product profiles,research and development

The 2027 IPCC Methodology Report on Inventories for Short-lived Climate Forcers (SLCFs) is an international initiative led by the Intergovernmental Panel on Climate Change (IPCC) to develop globally consistent methodological guidance for estimating and reporting national emissions of short-lived climate forcers. The report is intended to support co

Air pollution remains one of the most significant public health challenges of our time, with fine particulate matter (PM2.5) posing severe threats to vulnerable populations—particularly young children, the elderly, and those with preexisting health conditions. In urban centers such as Bangkok, where vehicular emissions, industrial activities, and

Climate change has triggered severe and widespread health crises globally, such as increased mortality rates and reduced productivity due to heatwaves, and heightened risks of infectious diseases driven by shifting climatic conditions. Consequently, it is imperative to integrate climate and environmental data into decision-making processes for heal

Situation of Clean Air Rooms and Air Purifiers in Thailand Thailand continues to experience persistent fine particulate matter with a diameter of 2.5 micrometers or less (PM2.5), posing significant risks to public health, particularly among vulnerable populations. About 13.6 mill

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

Abstract Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa